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Virtual meeting, 15 March – 2 April 2021 
 
SUMMARY AND CONCLUSIONS 
Issued on 20 August 2021 
The second in a series of three meetings of an ad hoc Joint FAO/WHO Expert Consultation on Risk 
Assessment of Food Allergens was held from 15 March to 2 April 2021. The main purpose of this second 
meeting was to establish threshold levels in foods of the priority allergens1.  
If conditions had permitted, this meeting would have been held at FAO headquarters in Rome, Italy. 
Because of the travel restrictions and lock-downs due to the COVID-19 pandemic in many countries, the 
joint FAO/WHO secretariat was unable to convene a physical meeting. Therefore, the meeting was held 
as a videoconference using a virtual online platform. 
In view of the time differences in the countries of origin of the invited experts, the time for a 
videoconference was restricted to a 3-hour time slot (12:00–15:00 CET) each day. To make up for the 
usual daily length (8–10 hours) of a joint FAO/WHO scientific expert meeting and efficiencies associated 
with in-person meetings, virtual sessions were held daily over the course of three weeks.  
Dr René Crevel served as Chairperson.  
Dr Benjamin Remington served as rapporteur.  
An Expert Committee, comprising scientists, regulators, physicians, clinicians and risk managers from 
academia, government and the food industry were selected to participate in the second meeting of the 
FAO/WHO Expert Consultation on Risk assessment of Food Allergens.  
Establishing thresholds constitutes a critical first step to assessing the risk from allergens, as they are a 
characteristic of the hazard that allergens present to the food-allergic population. Their establishment is 
thus essential to evidence-based application of risk management and mitigation strategies, such as 
Precautionary Allergen Labelling (PAL), which are a focus of the Terms of Reference (ToR)2 for the third 
meeting. The Expert Committee followed the ToR as formulated, except that they considered the list of 
                                                            
1 http://www.fao.org/3/cb4653en/cb4653en.pdf  
2 http://www.fao.org/3/ca7121en/ca7121en.pdf  
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priority allergens decided at the first meeting of this FAO/WHO Consultation. The ToR clearly signaled that 
the Codex Committees looked to define threshold levels that were Health-Based Guidance Values (HBGV). 
Guided by the definition of HBGV in Environmental Health Criteria (EHC) 240 Chapter 53, The Expert 
Committee considered and deliberated the following four approaches to identify which one(s) is/are best 
suited to define threshold levels for food allergens: 
• Analytical-based,  
• No Observed Adverse Effect Level [NOAEL] + Uncertainty Factor [UF],  
• Benchmark Dose combined or not with the application of a Margin of Exposure, and  
• Probabilistic Hazard Assessment. 
Following discussions for each approach, the Expert Committee concurred that the principle of 
establishing a Benchmark Dose (without the application of a Margin of Exposure) and the Probabilistic 
Hazard Assessment approach most closely aligned with the charge. 
This document summarizes the conclusions of this meeting and is made available to facilitate the 
deliberations of the upcoming Codex Committee on Food Labelling (CCFL) and Codex Committee on Food 
Hygiene (CCFH). The full report of the meeting will be published as part of the Food Safety and Quality 
Series and will describe the scientific evidence available to the Expert Committee and its deliberations 
during the meeting.  
The meeting participants are listed in Annex 1 of this summary report. 
 
 








                                                            
3 https://www.who.int/publications/i/item/9789241572408  
The issuance of this document does not constitute formal publication. The document may, however, 
be freely reviewed, abstracted, reproduced or translated, in whole or in part, but not for sale or use in 
conjunction with commercial purposes. 
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Background and objective 
At its 45th session in May 2019, the CCFL requested FAO and WHO to provide scientific advice to validate, 
and if necessary, update the list of foods and ingredients in section 4.2.1.4 of GSLPF (General standard for 
the labelling of prepackaged foods) (FAO and WHO, 2019). This request was addressed at the first meeting 
of the Ad hoc Joint FAO/WHO Expert Consultation on Risk Assessment of Food Allergens by first 
establishing the criteria for assessing additions and exclusions to the priority food allergen list, then 
evaluating the available evidence for foods of concern. The establishment of “thresholds below which the 
majority of allergic consumers would not suffer an adverse reaction” for the priority allergens identified 
at the first meeting forms part of the Codex requests. 
In response to the requests from the CCFH (FAO and WHO, 2018), the objectives of the expert consultation 
were: 
• What are the threshold levels for the priority allergens below which the majority of allergic consumers 
would not suffer an adverse reaction? 
• For the priority allergens, what are appropriate analytical methods for testing food and surfaces? 
• What should be the minimum performance criteria for these different analytical methods? 
Thus, FAO and WHO re-convened the Ad hoc Joint FAO/WHO Expert Consultation on Risk Assessment of 
Food Allergens for a second meeting to provide scientific advice on this subject (Annex 2). 
 
Conclusions 
Based on the defined approach, the Expert Committee discussed and agreed on the safety objective, 
which could be described as “to minimise, to a point where further refinement does not meaningfully 
reduce health impact, the probability of any clinically relevant objective allergic response, as defined by 
dose distribution modelling of minimum eliciting doses (MEDs) and supported by data regarding severity 
of symptoms in the likely range of envisioned Reference Doses (RfD)”. The Committee further identified 
several important considerations to guide decision-making. These included a clear definition of criteria to 
be met by quantitative data on which reference doses (RfD) are based, supporting data on health 
manifestations (severity) at the proposed RfD, quality, quantity, availability and accessibility of data (for 
priority allergens), as well as how to deal with priority allergens for which information supporting one or 
more of those considerations was lacking. 
The Expert Committee then considered the form of the outputs, starting from eliciting dose (ED) values 
predicted to result in objective reactions in no more than 1% (ED01) and 5% (ED05) of the allergic 
population for the priority allergens. These ED values have already been shown to be protective in single 
dose challenge studies for peanut and milk, but also through general experience with VITAL 2.0/3.0, and 
evaluations by expert committees such as Belgium’s Scientific Committee Of The Federal Agency For The 
Safety Of The Food Chain (FASFC).They agreed as a general principle that the RfD values should be 
contextualised, taking into account the wider and unintended consequences. Importantly, they concluded 
that a guiding principle should be whether selecting a more stringent (lower) ED value would materially 
improve the public health impact. 
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As data availability and quality are critical to the sound derivation of EDp4 values, the Expert Committee 
discussed potential data sources. They noted that the data reported in the publications of Remington, et 
al., (2020) and Houben, et al., (2020) were the most comprehensive and best described source available, 
both in terms of content and curation, with supportive peer-reviewed publications. Dose-distribution 
analysis methodology was similarly well-described within this dataset. The Committee reviewed the data 
sources for each priority allergen, taking into consideration both included publications and those which 
had been collated but excluded, and the extent and type of bias in the data. 
Characterising the hazard forms a critical component of risk assessment and considers both the 
numbers of people with the relevant allergy who will be affected by exposure to any given amount of 
allergen and the characteristics of any reaction that may occur. The first element is covered by dose-
distribution modelling, which is now well understood and developed. The second element is an 
evaluation of the likely health impact. A key factor that impacts the health of allergic individuals is 
reaction severity. Severity is a complex and multidimensional concept with an ill-defined relationship to 
dose; as such severity data suitable for modelling are limited. Two principal sources of data were 
reviewed: 1) evidence of anaphylactic reactions in clinical data at defined doses and 2) data on 
symptoms associated with reactions up to and including the ED01, ED05 and ED10 reported by 
Remington, et al. (2020) and Houben, et al. (2020). The latter indicated that all symptoms up to ED05 fell 
into a mild or moderate category, while analysis of clinical data indicated that up to 5% of reactions at 
both ED01 and ED05 could be classed as anaphylaxis, although none were severe, based on the World 
Allergy Organisation definition. Furthermore, the Committee noted the extreme rarity of fatal food 
anaphylaxis (1 per 100000 person-years in the allergic population) and observed that no fatal reactions 
had been observed following exposure to doses at or below those considered for RfD (i.e. the ED01 and 
the ED05). Considering both the proportion of individuals potentially affected and the severity 
characteristics of reactions at ED01 and ED05, including the absence of reports of severe anaphylaxis, 
the Committee agreed that, for all priority allergens, the safety objective would be met by starting the 
definition of RfD at the ED05 (as evaluated using the data from Remington, et al. (2020) and Houben, et 
al. (2020)). To make the application simpler, the Committee further simplified its recommendations by 
rounding the ED05 values down to one significant figure (with some exceptions for allergens with 
limited data). Those foods with close ED05 values were then grouped together and a single value 
derived for the RfD, further rounding down the value, if necessary. The resulting RfDs as mg of protein 












                                                            
4“EDp” designates a population threshold, where “p” defines the proportion (%) predicted to react at that 
threshold (dose). 
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(mg total protein from the allergenic source) 
Walnut (and Pecan*) 1.0 








Milk [decision pending based on further data analysis] 
Sesame [decision pending based on further data analysis] 




The Committee further incorporated into their recommendations action levels, using approaches applied 
for other food hazards. The action levels were calculated for different intakes of the affected food 
(containing potential unintended allergen), ranging from 10g to 510g in 10g increments. 
Examining assay capability in relation to the recommended RfD, the Committee observed that RfD can be 
implemented and monitored to some degree with current analytical capabilities but acknowledged that 
significant limitations in method performance exist. They strongly recommended that expression of 
analytical results be standardized as mg total protein of the allergenic food per kg food product analysed, 
in order to facilitate result interpretation and comparison with a RfD and action level by users of analytical 
services. To address deficiencies in analytical methodology, they recommended the development of 
method performance criteria, as well as more extensive provision of accessible reference materials for 
the priority allergens. Experts also identified the need for better understanding of assay performance in 
different food matrices and greater transparency over assay-specific reagents, such as antibodies used in 
ELISA, which are critical to assay performance. Improvements were also called for in sampling for analysis 
and curation of samples from originator to laboratory. 
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Annex 2. Meeting plan of the Ad hoc Joint FAO/WHO Expert Consultation on Risk Assessment of Food 
Allergens 
Meeting 1: Review and validation of Codex priority allergen list through risk assessment (November – 
December 2020) 
I. Whether the published criteria for assessing additions and exclusions to the list is still current and 
appropriate. 
II. Subject to the advice on the criteria above: 
• Whether there are foods and ingredients that should be added to or deleted from the list. 
• Clarification of the groupings of foods and ingredients in the list. 
• Whether certain foods and ingredients, such as highly refined foods and ingredients, that 
are derived from the list of foods known to cause hypersensitivity can be exempted from 
mandatory declaration. 
 
Meeting 2: Review and establish threshold levels in foods of the priority allergens (March – April 2021) 
I. What are the threshold levels for the priority allergens below which the majority of allergic 
consumers would not suffer an adverse reaction?  
II. For the priority allergens, what are appropriate analytical methods for testing food and surfaces? 
III. What should be the minimum performance criteria for these different analytical methods? 
 
 
Meeting 3: Review and evaluate the evidence in support of precautionary labelling (October 2021) 
I. What methods/tools are available for FBOs to determine:  
• whether allergen cross-contact is reasonably likely to occur in a food after a cleaning 
procedure;  
• whether allergen cross-contact is reasonably likely to occur from equipment used for 
foods with different allergen profiles; and  
• the level of allergen in a food resulting from cross-contact? 
II. Guidance on precautionary labelling. 
• The use of scientifically based threshold levels to evaluate risk for consumers with food 
allergies. 
• Determine the conditions for using the precautionary allergen labelling. 
III. How can thresholds be used by FBOs to determine:  
• the extent to which a cleaning procedure removes an allergen to a level that prevents or 
minimises the risk to the majority of allergic consumers from allergen cross-contact; and 
• whether an ingredient that contains a low level of an allergen (e.g. an ingredient with a 
precautionary allergen label) warrants control of its use to prevent or minimise allergen 
cross-contact? 
 
